Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Briggs

Showing results (371-380 of 475) with videos related to

Pageof 48
Sort By:
Blood|April 15, 1994
The human myeloid cell nuclear differentiation antigen gene is one of at least two related interferon-inducible genes located on chromosome 1q that are expressed specifically in hematopoietic cellsR C Briggs, J A Briggs, J Ozer, et al.
Alzheimer Disease and Associated Disorders|January 1, 1995
Potential treatment of Alzheimer disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like, and cytoprotective propertiesS P Arneric, J P Sullivan, M W Decker, et al.
Journal of Clinical Immunology|December 22, 2018
DDX58 and Classic Singleton-Merten SyndromeCarlos R Ferreira, Yanick J Crow, William A Gahl, et al.
Proceedings of the Western Pharmacology Society|January 1, 1995
Cholinergic channel activators: novel opportunities for the treatment of CNS disordersJ P Sullivan, M W Decker, D Donnelly-Roberts, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1994
(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterizationS P Arneric, J P Sullivan, C A Briggs, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 19, 2022
Use of Advanced Flexible Modeling Approaches for Survival Extrapolation from Early Follow-up Data in two Nivolumab Trials in Advanced NSCLC with Extended Follow-upM A Chaudhary, M Edmondson-Jones, G Baio, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2012
SAR of α7 nicotinic receptor agonists derived from tilorone: exploration of a novel nicotinic pharmacophoreMichael R Schrimpf, Kevin B Sippy, Clark A Briggs, et al.
Assay and Drug Development Technologies|August 20, 2009
Evaluation of alpha7 nicotinic acetylcholine receptor agonists and positive allosteric modulators using the parallel oocyte electrophysiology test stationJohn Malysz, Jens H Grønlien, Daniel B Timmermann, et al.
Methodsx|November 22, 2022
Fabrication methods for high reflectance dielectric-metal point contact rear mirror for optoelectronic devicesMadhan K Arulanandam, Myles A Steiner, Eric J Tervo, et al.
Journal of Clinical Immunology|December 13, 2016
Assessment of Type I Interferon Signaling in Pediatric Inflammatory DiseaseGillian I Rice, Isabelle Melki, Marie-Louise Frémond, et al.
Pageof 48

Showing results (371-380 of 475) with videos related to

Sort By:
Pageof 48
Blood|April 15, 1994
The human myeloid cell nuclear differentiation antigen gene is one of at least two related interferon-inducible genes located on chromosome 1q that are expressed specifically in hematopoietic cellsR C Briggs, J A Briggs, J Ozer, et al.
Alzheimer Disease and Associated Disorders|January 1, 1995
Potential treatment of Alzheimer disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like, and cytoprotective propertiesS P Arneric, J P Sullivan, M W Decker, et al.
Journal of Clinical Immunology|December 22, 2018
DDX58 and Classic Singleton-Merten SyndromeCarlos R Ferreira, Yanick J Crow, William A Gahl, et al.
Proceedings of the Western Pharmacology Society|January 1, 1995
Cholinergic channel activators: novel opportunities for the treatment of CNS disordersJ P Sullivan, M W Decker, D Donnelly-Roberts, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1994
(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterizationS P Arneric, J P Sullivan, C A Briggs, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 19, 2022
Use of Advanced Flexible Modeling Approaches for Survival Extrapolation from Early Follow-up Data in two Nivolumab Trials in Advanced NSCLC with Extended Follow-upM A Chaudhary, M Edmondson-Jones, G Baio, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2012
SAR of α7 nicotinic receptor agonists derived from tilorone: exploration of a novel nicotinic pharmacophoreMichael R Schrimpf, Kevin B Sippy, Clark A Briggs, et al.
Assay and Drug Development Technologies|August 20, 2009
Evaluation of alpha7 nicotinic acetylcholine receptor agonists and positive allosteric modulators using the parallel oocyte electrophysiology test stationJohn Malysz, Jens H Grønlien, Daniel B Timmermann, et al.
Methodsx|November 22, 2022
Fabrication methods for high reflectance dielectric-metal point contact rear mirror for optoelectronic devicesMadhan K Arulanandam, Myles A Steiner, Eric J Tervo, et al.
Journal of Clinical Immunology|December 13, 2016
Assessment of Type I Interferon Signaling in Pediatric Inflammatory DiseaseGillian I Rice, Isabelle Melki, Marie-Louise Frémond, et al.
Pageof 48